ZEB1 inhibits the epithelial splicing regulatory protein 1 (ESRP1), triggering a change from the epithelial-specific CD44v isoform to the standard CD44s isoform, which maintains the stemness and mesenchymal characteristics of cancer cells [78]. Here, ZEB1 is linked to cancer.